NCT02850796 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Palmeira L, Pinto-Gouveia J, Cunha M
The role of weight self-stigma on the quality of life of women with overweight and obesity: A multi-group comparison between binge eaters and non-binge eaters. Appetite. 2016 Jul 13. pii: S0195-6663(16)30282-3. doi: 10.1016/j.appet.2016.07.015. [Epub ahead of print]
Palmeira,L
,Cunha, M.,Pinto-Gouveia, J., Carvalho, S., & Lillis, J. (2016) New developments in the assessment of weight-related experiential avoidance (AAQW-Revised). Journal of Contextual Behavioral Science, in press. http://dx.doi.org/10.1016/j.jcbs.2016.06.001i

Kg-Free: an Acceptance, Mindfulness and Compassionate-based Intervention for Women Struggling With Their Weight: A Randomized Controlled Trial

Clinical trial NCT02850796 - References